Narayana Hrudayalaya (NSEI:NH) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

NH Panoramica delle azioni

Narayana Hrudayalaya Limited si occupa di servizi medici e sanitari in India e a livello internazionale.

NH analisi fondamentale
Punteggio fiocco di neve
Valutazione	4/6
Crescita futura	3/6
Prestazioni passate	4/6
Salute finanziaria	6/6
Dividendi	3/6

Premi

Negoziato a 6.6% al di sotto della nostra stima del suo valore equo

Si prevede che gli utili cresceranno del 10.16% all'anno

Gli utili sono cresciuti del 49.6% all'anno negli ultimi 5 anni

Negoziato a un buon valore rispetto ai pari e al settore

Analisi del rischio

Andamento instabile dei dividendi

Narayana Hrudayalaya Limited Concorrenti

Krishna Institute of Medical Sciences

NSEI:KIMS

₹195.4b

Global Health

NSEI:MEDANTA

₹289.9b

Fortis Healthcare

NSEI:FORTIS

₹400.9b

Rainbow Children's Medicare

NSEI:RAINBOW

₹123.1b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Narayana Hrudayalaya
Prezzi storici delle azioni
Prezzo attuale dell'azione	₹1,268.95
Massimo di 52 settimane	₹1,444.90
Minimo di 52 settimane	₹979.95
Beta	0.46
1Variazione di 1 mese	1.07%
Variazione a 3 mesi	1.29%
Variazione di 1 anno	24.66%
3Variazione a 3 anni	154.76%
Variazione a 5 anni	443.68%
Variazione dall'IPO	276.60%

Notizie e aggiornamenti recenti

Does Narayana Hrudayalaya (NSE:NH) Deserve A Spot On Your Watchlist?

Jul 20

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Jun 16

Recent updates

Does Narayana Hrudayalaya (NSE:NH) Deserve A Spot On Your Watchlist?

Jul 20

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Jun 16

Impressive Earnings May Not Tell The Whole Story For Narayana Hrudayalaya (NSE:NH)

Jun 01

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Apr 09

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Mar 20

If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity

Mar 04

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Dec 20

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Dec 05

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Nov 08

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Oct 21

Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt

Aug 01

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Jul 07

The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested

Jun 22

With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case

Jan 19

We Think Shareholders Will Probably Be Generous With Narayana Hrudayalaya Limited's (NSE:NH) CEO Compensation

Aug 20

Narayana Hrudayalaya's (NSE:NH) Returns On Capital Are Heading Higher

Aug 07

Is Narayana Hrudayalaya (NSE:NH) Using Too Much Debt?

Dec 10

Rendimenti per gli azionisti

	NH	IN Healthcare	IN Mercato
7D	7.7%	3.1%	3.4%
1Y	24.7%	42.0%	44.3%

Ritorno vs Industria: NH ha avuto una performance inferiore rispetto al Indian Healthcare che ha registrato un rendimento 43.5 % nell'ultimo anno.

Rendimento vs Mercato: NH ha avuto una performance inferiore al mercato Indian che ha registrato un rendimento 43.6 % nell'ultimo anno.

Volatilità dei prezzi

Is NH's price volatile compared to industry and market?
NH volatility
NH Average Weekly Movement	3.9%
Healthcare Industry Average Movement	6.0%
Market Average Movement	6.8%
10% most volatile stocks in IN Market	9.7%
10% least volatile stocks in IN Market	4.4%

Prezzo delle azioni stabile: NH non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 3% ) di NH è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2000	11,659	Emmanuel Rupert	www.narayanahealth.org

Narayana Hrudayalaya Limited si occupa di servizi medici e sanitari in India e a livello internazionale. Opera attraverso due segmenti: Servizi medici e sanitari e Altri. La società acquisisce, possiede e gestisce ospedali, cliniche, centri sanitari, centri diagnostici, case di cura e altre attività correlate.

Narayana Hrudayalaya Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Narayana Hrudayalaya con la sua capitalizzazione di mercato?
NH statistiche fondamentali
Capitalizzazione di mercato	₹255.22b
Guadagni(TTM)	₹8.07b
Ricavi(TTM)	₹51.26b

31.9x

Rapporto P/E

5.0x

Rapporto P/S

NH è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
NH Conto economico (TTM)
Ricavi	₹51.26b
Costo del fatturato	₹30.36b
Profitto lordo	₹20.89b
Altre spese	₹12.83b
Guadagni	₹8.07b

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	39.72
Margine lordo	40.76%
Margine di profitto netto	15.74%
Rapporto debito/patrimonio netto	56.4%

Come si è comportato NH nel lungo periodo?

Vedi performance storica e confronto

Dividendi

0.3%

Rendimento attuale del dividendo

10%

Rapporto di remunerazione

NH Panoramica delle azioni

Premi

Analisi del rischio

Narayana Hrudayalaya Limited Concorrenti

NSEI:KIMS

₹195.4b

NSEI:MEDANTA

₹289.9b

NSEI:FORTIS

₹400.9b

NSEI:RAINBOW

₹123.1b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

First quarter 2025 earnings: EPS exceeds analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2025 Results on Aug 02, 2024

Upcoming dividend of ₹4.00 per share

Does Narayana Hrudayalaya (NSE:NH) Deserve A Spot On Your Watchlist?

High number of new directors

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Recent updates

First quarter 2025 earnings: EPS exceeds analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2025 Results on Aug 02, 2024

Upcoming dividend of ₹4.00 per share

Does Narayana Hrudayalaya (NSE:NH) Deserve A Spot On Your Watchlist?

High number of new directors

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Impressive Earnings May Not Tell The Whole Story For Narayana Hrudayalaya (NSE:NH)

Full year 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited Recommends Final Dividend for the Year Ended 31St March, 2024

Narayana Hrudayalaya Limited to Report Q4, 2024 Results on May 24, 2024

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity

Price target increased by 8.1% to ₹1,390

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 16%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Price target increased by 8.2% to ₹1,070

Consensus EPS estimates increase by 11%

Narayana Hrudayalaya Limited Approves Dividend for the Financial Year Ended March 31, 2023

Narayana Hrudayalaya Limited Announces Board Retirements, Effective August 7, 2023

Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt

Narayana Hrudayalaya Limited to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended March 31, 2023

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Upcoming dividend of ₹2.50 per share at 0.3% yield

The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested

Price target increased by 7.5% to ₹943

Full year 2023 earnings released: EPS: ₹29.85 (vs ₹16.85 in FY 2022)

Narayana Hrudayalaya Limited, Annual General Meeting, Aug 04, 2023

Narayana Hrudayalaya Limited to Report Q4, 2023 Results on May 19, 2023

Price target increased by 7.4% to ₹878

Narayana Hrudayalaya Limited Announces Board Appointments

Narayana Hrudayalaya Limited to Report Q3, 2023 Results on Feb 08, 2023

Narayana Hrudayalaya Limited Files Application for Strike-Off of Name of Wholly Owned Subsidiary, Narayana Health Institutions Private Limited

With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case

Insufficient new directors

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q2, 2023 Results on Nov 09, 2022

Narayana Hrudayalaya Limited (NSEI:NH) acquired Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited.

Narayana Hrudayalaya (NSE:NH) Seems To Use Debt Rather Sparingly

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited Approves the Dividend for the Financial Year Ended 31 March 2022

Upcoming dividend of ₹1.00 per share

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Is Well Worth Watching

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended 31 March 2022

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2023 Results on Aug 08, 2022

Narayana Health Announces Appointment of Ashish Bajaj as the Chief Marketing Officer

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Full year 2022 earnings: EPS misses analyst expectations